This is a snippet of the transcript, sign up to read more.
I would say it's a combination. It's not that Sectra won't support on-premises, but they mainly market and invest in their cloud solutions. Customers see this as the most attractive option. From a customer perspective, you don't need to maintain hardware in your basement, and you mitigate risks like server downtime. You transfer that responsibility and risk to the supplier, Sectra, which is quite attractive. It's similar to having Microsoft Office on the cloud instead of purchasing it from a store. You want it to run all the time with the latest updates.
This is a snippet of the transcript, sign up to read more.
As it stands now, they are reporting recurring revenue, of which a portion is cloud-based. The more customers that transition to the cloud, the recurring revenues that are currently not cloud-based will become cloud-based. The recurring revenue that is not cloud-based is mainly on-premises maintenance and support revenues. These will transition to cloud, and you will also gain the hosting and license portions as cloud revenue. So, it might be roughly double. At least something more than what is in the recurring today will be transferred into the cloud recurring.
This is a snippet of the transcript, sign up to read more.
Yes, I would assume so. If you look at the non-recurring revenues for the medical imaging part, you have contracts where a customer wants an on-premises solution and prefers a single supplier. This means they might also want to purchase hardware from Sectra. Sectra sells the servers, which is a significant amount.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research